Table 1.
Basic information about patients with HCC.
| Factor | Number | Percentage |
|---|---|---|
| Sex | ||
| Female | 37 | 31.62% |
| Male | 80 | 68.38% |
| Age | ||
| <50 | 46 | 39.32% |
| ≥50 | 71 | 60.68% |
| Tumor size (cm) | ||
| ≤5 | 45 | 38.46% |
| >5 | 72 | 61.54% |
| Tumor number | ||
| Single | 107 | 91.45% |
| Multiple | 10 | 8.55% |
| Histopathological grade | ||
| I+II | 84 | 71.79% |
| III | 33 | 28.21% |
| HBsAg | ||
| Negative | 36 | 30.77% |
| Positive | 81 | 69.23% |
| HCV | ||
| Negative | 107 | 91.45% |
| Positive | 10 | 8.55% |
| Microvascular invasion | ||
| Negative | 54 | 46.15% |
| Positive | 63 | 53.85% |
| Cirrhosis | ||
| Negative | 63 | 53.85% |
| Positive | 54 | 46.15% |
| T stage | ||
| I+II | 57 | 48.72% |
| III+IV | 60 | 51.28% |
| N stage | ||
| N0 | 115 | 98.29% |
| N1 | 2 | 1.71% |
| TNM stage | ||
| I+II | 57 | 48.72% |
| III+IV | 60 | 51.28% |
| DAAM1 | ||
| Low | 95 | 81.20% |
| High | 22 | 18.80% |
| DAAM2 | ||
| Low | 60 | 51.28% |
| High | 57 | 48.72% |
HCV – hepatitis C virus.